nedaplatin has been researched along with Emesis in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Jiang, Y; Song, B | 1 |
| Igaki, H; Kobayashi, R; Nakagawa, K; Okuma, K; Omori, M; Yamashita, H | 1 |
| Ando, T; Fujinami, H; Hosokawa, A; Kajiura, S; Mihara, H; Minemura, M; Nishikawa, J; Ogawa, K; Sugiyama, T; Ueda, A; Ueda, Y; Yoshita, H | 1 |
| Shi, L; Tang, Y; Teng, XZ; Wang, W | 1 |
| Qiu, ZQ; Zhao, K | 1 |
| Aiba, K; Baba, H; Baba, Y; Kitagawa, Y; Miyazaki, T; Nakajima, Y; Shibata, T; Shimada, H; Shimokawa, M; Tsuji, Y; Yamamoto, S; Yoshikawa, T | 1 |
| Chen, XB; Fan, QX; Geng, L; Han, JW; Jiao, ZM; Lu, P; Lu, SP; Lu, TY; Luo, SX; Ma, ZY; Song, M; Wang, GJ; Wang, JS; Wang, R; Wang, RL; Wu, XA; Zhang, MZ; Zhao, YF | 1 |
| Cai, L; Cong, YY; Liu, MY | 1 |
| Chen, ZW; Gu, LP; Shen, SP | 1 |
| Cao, KJ; Huang, PY; Luo, DH; Ma, WJ; Xia, WX; Zhang, AL | 1 |
| Li, T; Yu, CH; Zhu, WG | 1 |
| Bi, LW; Zhang, LZ; Zhao, HF | 1 |
| Hatae, M; Hirabayashi, K; Kanazawa, K; Noda, K; Ozaki, M; Terashima, Y; Yakushiji, M | 1 |
| Arai, M; Kato, T; Nishimura, H; Noda, K; Ota, M; Suzuki, M; Takamizawa, H; Takeuchi, S; Terashima, Y; Yakushiji, M | 1 |
| Koyama, H; Kuraishi, Y; Ogawa, M; Taguchi, T; Tominaga, K; Yoshida, M | 1 |
8 trial(s) available for nedaplatin and Emesis
| Article | Year |
|---|---|
Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-Fluorouracil Treatment.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorouracil; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Nausea; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Taxoids; Treatment Failure; Vomiting | 2016 |
Efficacy of S-1 plus nedaplatin compared to standard second-line chemotherapy in EGFR-negative lung adenocarcinoma after failure of first-line chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Drug Combinations; Drug Therapy; ErbB Receptors; Female; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Mutation; Nausea; Neoplasm Staging; Organoplatinum Compounds; Oxonic Acid; Tegafur; Treatment Failure; Treatment Outcome; Vomiting | 2014 |
Expression of ERCC1, RRM1 and LRP in non-small cell lung cancers and their influence on chemotherapeutic efficacy of gemcitabine concomitant with nedaplatin.
Topics: Acute Kidney Injury; Adenocarcinoma; Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; DNA-Binding Proteins; Drug Resistance, Neoplasm; Endonucleases; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Nausea; Organoplatinum Compounds; Ribonucleoside Diphosphate Reductase; Thrombocytopenia; Treatment Outcome; Tumor Suppressor Proteins; Vault Ribonucleoprotein Particles; Vomiting | 2014 |
[Comparison of the therapeutic effects of pleural perfusion of NDP and cDDP in NSCLC patients with malignant pleural effusion].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dexamethasone; Drainage; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Pleural Effusion, Malignant; Quality of Life; Survival Rate; Vomiting | 2010 |
[Nedaplatin or cisplatin combined with 5-fluorouracil for treatment of stage III-IVa nasopharyngeal carcinoma: a randomized controlled study].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Nausea; Neoplasm Staging; Organoplatinum Compounds; Remission Induction; Vomiting | 2011 |
[Combination chemotherapy with nedaplatin, bleomycin and ifosfamide for advanced cervical cancer of the uterus--a preliminary study for phase III clinical study].
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Ifosfamide; Middle Aged; Nausea; Organoplatinum Compounds; Pilot Projects; Uterine Cervical Neoplasms; Vomiting | 1997 |
[Phase II study of 254-S (cis-diammine glycolato platinum) for gynecological cancer].
Topics: Adult; Aged; Anorexia; Antineoplastic Agents; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms; Vomiting | 1992 |
[A phase II clinical study of cis-diammine glycolato platinum, 254-S, for advanced breast cancer].
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Middle Aged; Nausea; Organoplatinum Compounds; Vomiting | 1992 |
7 other study(ies) available for nedaplatin and Emesis
| Article | Year |
|---|---|
Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer and Tumor Marker Analysis: Based on a Retrospective Analysis.
Topics: Abdominal Pain; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Case-Control Studies; Chemotherapy, Adjuvant; Cisplatin; Diarrhea; Exanthema; Female; Humans; Hyperglycemia; Irinotecan; Nausea; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Retrospective Studies; Uterine Cervical Neoplasms; Vomiting | 2022 |
Longitudinal assessments of quality of life and late toxicities before and after definitive chemoradiation for esophageal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Esophageal Neoplasms; Female; Fluorouracil; Humans; Longitudinal Studies; Male; Middle Aged; Nausea; Organoplatinum Compounds; Quality of Life; Surveys and Questionnaires; Time Factors; Treatment Outcome; Vomiting | 2014 |
Chemotherapy-induced nausea and vomiting is less controlled at delayed phase in patients with esophageal cancer: a prospective registration study by the CINV Study Group of Japan.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Cisplatin; Esophageal Neoplasms; Female; Humans; Incidence; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Nausea; Organoplatinum Compounds; Prospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Treatment Outcome; Vomiting | 2017 |
[Nedaplatin combined with tegafur in the treatment for advanced esophageal cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Remission Induction; Survival Rate; Tegafur; Vomiting | 2008 |
[Comparison of the efficacy of nedaplatin combined with docetaxel and docetaxel alone as a second line treatment for advanced non-small cell lung cancer].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Docetaxel; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Retrospective Studies; Survival Rate; Taxoids; Vomiting | 2010 |
[Dose escalation of domestic nedaplatin used in concurrent chemoradiotherapy for cervical cancer].
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Diarrhea; Dose-Response Relationship, Drug; Female; Humans; Leukopenia; Middle Aged; Organoplatinum Compounds; Radiotherapy, Conformal; Thrombocytopenia; Uterine Cervical Neoplasms; Vomiting | 2011 |
[Efficacy of docetaxel and nedaplatin combined with concurrent intensity modulated radiation therapy in the treatment of esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Esophagitis; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Organoplatinum Compounds; Radiotherapy, Intensity-Modulated; Remission Induction; Survival Rate; Taxoids; Vomiting | 2012 |